Morgan Stanley X4 Pharmaceuticals, Inc Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in X4 Pharmaceuticals, Inc stock. As of the latest transaction made, Morgan Stanley holds 490,664 shares of XFOR stock, worth $166,825. This represents 0.0% of its overall portfolio holdings.

Number of Shares

490,664

Previous 229,336 113.95%

Holding current value

$166,825

Previous $133,000 146.62%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$0.54 - $0.86 $141,117 - $224,742	261,328 Added 113.95%	490,664 $328,000
Q2 2024 Oct 17, 2024	SELL	$0.58 - $1.47 $682,711 - $1.73 Million	-1,177,089 Reduced 83.69%	229,336 $133,000
Q2 2024 Aug 14, 2024	SELL	$0.58 - $1.47 $682,711 - $1.73 Million	-1,177,089 Reduced 83.69%	229,336 $133,000
Q1 2024 Oct 17, 2024	BUY	$0.72 - $1.46 $847,504 - $1.72 Million	1,177,089 Added 513.26%	1,406,425 $1.95 Million
Q1 2024 Aug 16, 2024	BUY	$0.72 - $1.46 $723,636 - $1.47 Million	1,005,051 Added 250.4%	1,406,425 $1.95 Million
Q1 2024 May 15, 2024	BUY	$0.72 - $1.46 $723,636 - $1.47 Million	1,005,051 Added 250.4%	1,406,425 $1.95 Million
Q4 2023 Aug 16, 2024	BUY	$0.61 - $0.99 $104,943 - $170,317	172,038 Added 75.02%	401,374 $337,000
Q4 2023 Feb 13, 2024	BUY	$0.61 - $0.99 $97,374 - $158,033	159,630 Added 66.03%	401,374 $337,000
Q3 2023 Nov 15, 2023	BUY	$1.03 - $2.02 $44,187 - $86,658	42,900 Added 21.57%	241,744 $263,000
Q2 2023 Aug 14, 2023	BUY	$0.82 - $2.49 $100,563 - $305,371	122,639 Added 160.93%	198,844 $385,000
Q1 2023 May 15, 2023	BUY	$0.8 - $1.22 $118 - $180	148 Added 0.19%	76,205 $66,000
Q4 2022 Feb 14, 2023	BUY	$0.69 - $2.21 $12,985 - $41,592	18,820 Added 32.88%	76,057 $75,000
Q3 2022 Nov 14, 2022	BUY	$0.89 - $1.71 $48,113 - $92,442	54,060 Added 1701.61%	57,237 $97,000
Q2 2022 Oct 27, 2022	SELL	$0.88 - $1.91 $5,044 - $10,948	-5,732 Reduced 64.34%	3,177 $3,000
Q2 2022 Aug 15, 2022	SELL	$0.88 - $1.91 $5,044 - $10,948	-5,732 Reduced 64.34%	3,177 $3,000
Q1 2022 Oct 27, 2022	BUY	$1.48 - $2.58 $8,483 - $14,788	5,732 Added 180.42%	8,909 $16,000
Q1 2022 May 13, 2022	SELL	$1.48 - $2.58 $4,660 - $8,124	-3,149 Reduced 26.12%	8,909 $16,000
Q4 2021 Feb 14, 2022	BUY	$1.9 - $5.6 $6,190 - $18,244	3,258 Added 37.02%	12,058 $27,000
Q3 2021 Nov 15, 2021	BUY	$4.53 - $6.45 $39,864 - $56,760	8,800 New	8,800 $46,000

Others Institutions Holding XFOR

# of Institutions

105

Shares Held

100M

Call Options Held

213K

Put Options Held

50.6K

View Full List

About X4 Pharmaceuticals, Inc

Ticker XFOR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,646,096
Market Cap $23.3M
Description
X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase...

More about XFOR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account